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Background: The purpose of this study was to examine the possible contribution of calcifying 
nanoparticles to the pathogenesis of placental calcification.
Methods: Calcified placental tissues and distal tissue samples were collected from 36 
  confirmed placental calcification cases. In addition, 20 normal placental tissue samples were 
obtained as a control group. All the tissue samples were cultured using special nanobacterial 
culture methods. The cultured calcifying nanoparticles were examined by transmission electron 
microscopy (TEM), and their growth was monitored by optical density (OD) at a wavelength of 
650 nm. 16S rRNA gene expression of the cultured calcifying nanoparticles was also isolated 
and sequenced.
Results: Novel calcifying nanoparticles wrapped with electron-dense shells between 50 nm 
to 500 nm in diameter were observed in the extracellular matrix of calcified placental tissues. 
They were detected in placental villi and hydroxyapatite crystals, and contained “nucleic acid-
like materials”. After isolation and four weeks of culture, 28 of 36 calcified placental tissue 
samples showed white granular precipitates attached to the bottom of the culture tubes. OD650 
measurements indicated that the precipitates from the calcified placental tissues were able to 
grow in culture, whereas no such precipitates from the control tissues were observed. The 16S 
rRNA genes were isolated from the cultured calcifying nanoparticles and calcified placental 
tissues, and their gene sequencing results implied that calcifying nanoparticles were novel 
nanobacteria (GenBank JF823648).
Conclusion: Our results suggest that these novel calcifying nanoparticles may play a role in 
placental calcification.
Keywords: calcifying nanoparticles, nanobacteria, placental calcification, 16S rRNA gene
Introduction
Placental calcification is a common pathological change of the placenta 
during pregnancy. In general, more than 50% of placentas have some degree 
of calcification and 18% of placentas show severe grade 3+ calcification after 
about 33 weeks of pregnancy.1 Early preterm placental calcification is associated 
with a higher incidence of detrimental outcomes, thus may serve as a diagnostic 
marker.2 Other studies have indicated that rickets in offspring are associated with 
placental calcification,3 and placental dysfunction during early gestation may 
play an important role in the development of hypospadias.4 In addition, calcium 
deposition is harmful for placental function and may cause severe complications 
in pregnancy, such as fetal distress, fetal growth restriction, fetal anomaly, and 
apnea neonatorum. Previous studies of calcified placentas are limited, and the 
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etiology of placental calcification remains undefined. Most 
clinicians believe that placental calcification results from 
hereditary and environmental factors, such as radiation, 
low frequency noises, or reactions to medication. Some 
studies indicate that smoking is not a factor exclusively 
responsible for forming calcium deposits in the placenta, 
and the consumption of vitamin supplements probably 
also involves calcification of placental tissues.5 Recently, 
interleukins 1 and 6, which are immunity-related 
cytokines, were identified in placental fluid from placental 
calcification cases,6 and Mycoplasma and other organisms 
were isolated from the placenta after cesarean section.7 
The results indicate that bacterial infections may play an 
important role in placental calcification.
Kajander and Ciftcioglu and Kajander et al proposed 
that calcifying nanoparticles may be responsible for some 
calcification diseases, which spurred a subdiscipline in 
nanoscale paleontology.8,9 These entities were described 
earlier in geological samples, including fossils,10 hot spring 
sediments,11,12 and a martian meteorite,13 indicating that 
nanobacteria may have existed throughout earth’s history. 
These bacteria, with diameters from 50 nm to 500 nm, are 
sterile and filterable. They contain a sodium carbonate salt 
shell, and are capable of self-mineralization in physiological 
conditions. These nanobacteria are implicated in many 
human diseases, including kidney and gallbladder stones, 
testicular microliths, chronic prostatitis, rheumatoid arthritis, 
dental pulp stones, salivary gland stones, ovarian cancer, 
and atherosclerosis.14–30 Calcifying nanoparticles were found 
to be opportunistic pathogens in 5% of Finns and 8% of 
Chinese individuals31 on blood testing. In addition, calcifying 
nanoparticle infections have also been observed in placental 
calcification and psammoma bodies.32,33 Nanobacteria grow 
faster in elevated phosphates than in normal culture medium, 
so may be implicated in placental calcification because 
elevated phosphates generally stimulate smooth muscle cell 
mineralization.34 Whether these self-mineralizing nanobacteria 
are bacterial or inorganic substances with the capacity for 
extensive crystallization is still in debate.35–37 Many of the 
16S rRNA gene sequences of nanobacteria in the GenBank 
are α-2 subgroups of Proteobacteria, such as Brucella 
and Bartonella species. Here we examine the morphology 
of calcifying nanoparticles under transmission electron 
microscopy (TEM), and characterize their biological growth 
properties with optical density (OD). In addition, 16S rRNA gene 
expression of calcifying nanoparticles was isolated, sequenced, 
and deposited into GenBank (GenBank JF823648).
Materials and methods
Clinical sample collection
All enrolled patients agreed to sign written consent forms and 
the study was approved by our institutional review board. 
Thirty-six pregnant women, aged 22–40 (median 33) years 
were diagnosed with placental calcification disease by ultra-
sound, and were scheduled to deliver by cesarean section. 
These pregnant women were enrolled in this study at the 
First Affiliated Hospital of Chongqing Medical University. 
None of the women had any other infectious diseases, such 
as Treponema pallidum, human immunodeficiency virus, or 
hepatitis B and C, and all underwent routine testing of blood, 
urine, and feces. Three biopsies from each patient’s placenta 
(about 50 mm3 of each sample) were collected immediately 
after removal of the placenta. They were kept in an ice-box 
for either immediate laboratory research or storage at −80°C. 
The control group biopsies were collected from the placental 
tissues of healthy pregnant women.
TEM of calcifying nanoparticles  
in calcified placental tissues
Fresh specimens from calcified placental tissues and normal 
tissue samples were cut into small pieces (about 1 mm3), 
fixed in 2.5% glutaraldehyde, post-fixed in 1% osmic acid, 
and dehydrated by a graded series of cold ethanol solutions 
before embedding in epoxy and being sliced into ultrathin 
sections. The thin sections were viewed under TEM to image 
the mineral microdeposits.38
Isolation and cultivation of calcifying 
nanoparticles
After removal of blood and villous tissue, the calcified 
placental tissue samples (around 100 mg) were ground, 
decalcified in 1 mol/L HCl for 30 minutes, and neutralized 
with 1 mol/L Tris, followed by centrifugation at 14,000 g 
for 40 minutes in normal saline and filtering with 0.22 µm 
Millipore filters. The samples were then incubated in a 
70°C water bath for 15 minutes to prevent contamination by 
Chlamydia and Mycoplasma. Next, 1 mL samples were mixed 
with 3 mL RPMI-1640 cell culture medium supplemented 
with 10% fetal bovine serum. The mixture was cultured in an 
incubator (37°C; 5%–10% CO2/90%–95% air) for 4 weeks, 
with medium changes every 3 days.8 Fetal bovine serum or 
normal saline was used as the vehicle control; and normal 
placental tissues which were decalcified and cultured under 
the same conditions were used as the negative control. All the 
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procedures were performed under aseptic conditions, and 
freedom from contamination by Chlamydia and Mycoplasma 
was verified after 4 weeks of culture.
Identification of cultured calcifying 
nanoparticles
After about 4 weeks of culturing, the calcifying nano  particles 
were harvested using a cell scraper, centrifuged at 14,000 g 
for 40 minutes, and washed for 5 minutes with PBS, repeated 
three times. The precipitates collected were then fixed in 2.5% 
glutaraldehyde, post-fixed in 1% osmic acid, dehydrated in 
ethanol, and embedded in epoxy as described above. The 
calcifying nanoparticle precipitates were observed using a 
Hitachi-600 TEM operated at 120 kV . Next, 200 µL aliquots 
of calcifying nanoparticles were placed in a 96-well plate in 
triplicate and OD was measured every three days at 650 nm 
using a microplate spectrophotometer (µQuant; Biotek, 
North Seattle, WA). The averages of the OD outcomes were 
recorded separately for each group.
16S rRNA gene expression of cultured 
calcifying nanoparticles
The cultured calcifying nanoparticle precipitates were first 
decalcified with 1 M HCl. Genomic DNA was then isolated 
from the decalcified precipitates using the Wizard® genomic 
DNA purification kit (Promega, Madison, WI) following 
the manufacturer’s instructions. 16S rDNA sequences for 
Nanobacterium sanguineum (Genbank X98418), Microscilla 
species Nano 1 (Genbank AB015937), and nanobacterium 
species NanoD (Genbank EF585587) were obtained from 
the National Center for Biotechnological Information, 
and multialigned using Vector NTI Suite 6.0. A pair of 
nanobacteria group-specific polymerase chain reaction 
(PCR) primers was designed and synthesized (Shanghai 
Bioasia Biotechnology Corporation Ltd, Shanghai, China) to 
amplify the 16S rDNA. The primer sequences are as follows: 
upstream primer (NanoA), 5′-CACCCCAGTCATCGGCCA
CACCGTGGCAA-3′; downstream primer (NanoB), 5′-AA
CGCTGGCGGTAGGCCTAACACATGCAA-3′. The PCR 
reaction solutions (50 µL) contained 250 ng of genomic DNA 
template, 10 pmol of each primer, 2.5 U of AmpliTaq DNA 
polymerase, 3 mM MgCl2, 50 mM KCl, 20 mM Tris-HCl, 
and 0.5 mM of each dNTP. Negative PCR controls were 
conducted without primers or templates or genomic DNA 
templates from normal placental tissues.
PCR reactions were performed with the GeneAmp PCR 
system 2400 (Perkin Elmer, Norwalk, CT). The thermal 
  program consisted of one cycle at 94°C (4 minutes), 35 cycles 
of 94°C for 30 seconds, 56°C for 20 seconds, and 68°C for 
40 seconds, and one cycle of 68°C for 10 minutes, then stored 
at 4°C. The PCR products were subjected to electrophoresis 
and the desired DNA bands were then purified with the PCR 
purification kit (Takara Biotechnology [Dalian] Co, Ltd, 
Dalian, China) according to the manufacturer’s instructions. 
The purified DNA products were inserted into a pMD18-T 
vector (Takara Biotechnology [Dalian] Co, Ltd) and trans-
formed into Escherichia coli DH5α. One microgram of puri-
fied plasmid was used for sequence analysis of the cloned 
16S rRNA gene fragments.
16S rRNA expression of calcifying 
nanoparticles in calcified placentas
Samples with calcium deposits and normal   placental 
samples were excised to isolate genomic placental 
DNA. A pair of PCR primers was designed against the 
newly-found 16S rRNA gene sequences from cultured 
calcifying nanoparticles: upstream primer (NanoA), 
5′-TAGGGTTTCTGGGATTGGC-3′; downstream primer 
(NanoB), 5′-ATTTGGCACGCAGTATCG-3′ (GenBank 
JF823648). Negative PCR controls were performed without 
primers or genomic DNA or genomic DNA from normal 
  placental tissues. The amplified fragment was purified, 
cloned, and analyzed as described elsewhere.
Results
Isolation of calcifying nanoparticles  
from calcified placental tissues
The morphology of calcifying nanoparticles under TEM 
in freshly-fixed calcified placental tissues was very similar 
to that described in other studies.32 In all the fixed calcified 
placental samples, the particles had an oval shape and 
were of different sizes, ranging from 50 nm to 500 nm in 
diameter. Each particle was wrapped by a thin shell with 
different electron densities (Figure 1A). We observed similar 
“nucleic acid-like materials” in the extracellular matrix of 
each individual particle as described by Agababov et al32 
(Figure 1B). Interestingly, one calcifying nanoparticle was 
seen in the process of self-dividing (Figure 1C). The calcifying 
nanoparticles were also seen in the uterus among placental 
villi (Figure 1D) and free hydroxyapatite crystals (Figure 1E). 
There was no evidence of needle precipitates or caves in 
placental tissues whereby these particles form hydroxyapatite 
crystals. In contrast, no calcifying nanoparticles were found 
in normal placental tissues under TEM.
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Figure 1 Transmission electron micrograph of calcifying nanoparticles. (A) Calcifying 
nanoparticles between 50 nm to 500 nm in diameter showing different electron-dense 
shells in calcified placental tissues. (B) Nucleic acid-like materials distributed within 
the  individual  calcifying  nanoparticles  in  the  extracellular  matrix.  (C)  A  calcifying 
nanoparticle self-divided into two. (D) Calcifying nanoparticles with thin shells exiting 
placental villus. (E) Single calcifying nanoparticles among hydroxyapatite crystals in 
calcified placental tissues. 
Note: Bar indicates magnification of 200 nm.
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Calcifying nanoparticle culture results
After 4 weeks of culture, the 36 calcified placental tissue 
samples were classified into three groups according to 
their adhesion and turbidity characteristics:13 Group 1, 
complete white precipitation adhered to the bottom of 
glass tubes; Group 2, white precipitation adhered to the 
bottom of the glass test tubes with flocculent floating 
debris; and Group 3, no particles. Twenty-eight   placental 
calcification samples (10 samples in Group 1 and 
18 samples in Group 2) were able to grow in culture. The 
negative controls and reagent controls were all classified 
in Group 3. OD650 measurements during culture indicated 
that the calcifying nanoparticles grew in a similar way to 
that of other bacteria (Figure 2). Significant differences 
were observed between the experimental group and the 
negative group, and no Chlamydia or Mycoplasma was 
detected.
A
B
ECM
200 nm
0.5 µm
1
2
3
3
Figure 1 (Continued)
Morphologic characteristics of cultured 
calcifying nanoparticles
Gram staining of the calcifying nanoparticle precipitates did 
not work well, and only some deep-colored particles with no 
stains could be observed under high-power magnification 
using light microscopy. In contrast, TEM is a powerful tool 
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to study calcifying nanoparticles. After four weeks of culture, 
oval-shaped particles with diameters of 200–400 nm were 
observed using TEM. These cultured particles were similar 
in size and shape to the calcifying nanoparticles detected 
in tissues, and each particle was either wrapped by a high 
electron-dense outer shell (Figure 3A) or without shells 
(Figure 3B). The needle-like features on the outer surfaces of 
the calcifying nanoparticles which were described in previous 
reports were not observed here.32
16S rRNA expression by calcifying 
nanoparticles
The predicted target 16S rRNA gene sequence of cultured 
calcifying nanoparticles is about 1500 base pairs in length 
(Figure 4). Our PCR-amplified DNA is 1470 base pairs in 
length, as indicated by DNA sequencing, and shares 83% 
similarity to the known 16S rRNA gene for nanobacteria 
(GenBank X98419). The novel 16S rRNA gene in placental 
calcification tissues (GenBank JF823648) was identified in 
11 calcified placenta samples (31%, Figure 4), while no target 
16S rRNA gene was detected in the controls (Figure 5). The 
sequence of the 16S rRNA gene (nanobacterial PCR) for 
placenta calcification is different to that of other nanobacteria 
in human stone disease, human blood, or fetal bovine serum. 
This novel 16S rRNA gene sequence was submitted to the 
NCBI GenBank database (GenBank JF823648).
Discussion
Nanobacteria are thought to promote the development 
of stone disease and calcified plaques in adults.39–41 
Putative nanobacteria have been described using both 
transmission and scanning electron microscopy, but the 
immunochemical specificity of these putative nanobacteria 
has not been established, and DNA staining (Hoechst 33258) 
at the concentration used did not stain the nanobacteria.42,43 
Furthermore, the 16S rRNA gene sequences reported for 
nanobacteria are thought to come from contaminating 
bacteria.44 Thus, many scientists consider nanobacteria as 
nonliving organic or inorganic substances with the capacity 
to aggregate and grow. Here, we showed that calcifying 
nanoparticles adhered to the bottom of glass culture tubes 
and displayed growth curves similar to other bacteria. 
“Nucleic acid-like materials” in the extracellular matrix 
of individual particles could be observed in placental 
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Figure 2 Growth curve of calcifying nanoparticles cultured in vitro under cell 
culture conditions. 
Note: Mean OD650 values were recorded up to 4 weeks.
Abbreviation: OD, optical density.
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Figure 3 Transmission electron micrograph of calcifying nanoparticles cultured 
in vitro for four weeks. (A) Calcifying nanoparticles appear as oval-shaped particles 
with highly electron-dense shells. (B) Calcifying nanoparticles without shells. 
Note: Bar indicates magnification of 200 nm.
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We initially attempted to isolate bacteria from the calcified 
tissue using normal culture methods and failed. Eventually, 
white precipitates (calcifying nanoparticles) were obtained 
using the culture methods described for nanobacteria. The 
16S rRNA genes amplified from the cultured calcifying 
nanoparticles in placental calcification tissues share 83% 
gene similarity with nanobacteria (GenBank X98419). 
They could not reach up to 98% gene similarity with the 
nanobacteria (GenBank X98419), as reported previously.15 
We have speculated that the calcifying nanoparticles in 
placental calcification are a novel type of nanoscale bacteria 
distinct from the nanobacteria isolated from kidney stones 
and human blood, as reported elsewhere.46 We assumed that 
  different nanobacteria may induce calcification by receptors 
in different human tissues, like nanobacteria receptor-
mediated tumor tissue calcification.
It is unlikely that the gene sequences seen in our study 
were from microbial contamination,47 because we did not 
detect Chlamydia and Mycoplasma contamination after four 
weeks of culture of calcifying nanoparticles. In addition, the 
homology of the 16S rRNA gene was so high that even only 
a few wrong bases may lead to failure of the sequence and a 
false group. Due to the small size of CNPs, decalcification 
and PCR may destroy their genetic material. Only part of the 
16SrRNA gene sequences compared to the GenBank may 
lead to wrong classification. 
In our study, we did not isolate calcifying   nanoparticles 
in all placental calcification samples, suggesting that the 
amounts in these samples was too small to isolate or they 
may have been lost in some steps. We could also say 
that   calcification depends on the amount of calcifying 
nanoparticles present.
Placental integrity is critical for proper embryonic 
development, and placental calcification may lead to diseases 
such as hypospadias and rickets.3,4 The mechanism for 
calcification remains undefined. Although the nanobacteria-
like particles which contain genetic-like materials were 
detected in placental calcification of early pregnancy, 
isolating and culturing nanoscale micro-organisms from 
placental calcification tissues have not been reported.48 In this 
work, we isolated nanobacteria from placental calcification 
tissues, grew them in cell culture conditions, and identified 
calcifying nanoparticles as nanobacteria by sequencing 
the 16S rRNA gene. Our study may help to establish the 
relationship between placental calcification and calcifying 
nanoparticles.
In the clinic, neonatal infections usually cannot be related 
to a specific pathogenic bacterium on microbiological 
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Figure 4 Analysis of target 16S rRNA gene sequences from different cultured 
calcifying nanoparticle samples. Lane M, DNA marker (Trans2K plus DNA marker); 
lane 1–6, genes from different calcifying nanoparticle samples cultured under the 
same conditions.
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Figure  5  Analysis  of  target  16S  rRNA  gene  sequences  from  different  samples 
of calcified placental tissues and normal placental tissues. Lane M, DNA marker 
(Trans2K plus DNA marker); lane 1, negative polymerase chain reaction control 
without  primers;  lane  2,  negative  polymerase  chain  reaction  control  without 
templates; lane 3–4, genes from normal placental tissues samples; lane 5–6, genes 
from different calcium samples.
calcification tissues under TEM. Consistent with previous 
studies,45 we also observed one particle in the process of 
self-dividing. In addition, we successfully detected the 
16S rRNA gene in calcifying nanoparticles isolated from 
placental calcification tissue, and the DNA sequencing 
results indicated that the calcifying nanoparticles are novel 
nanobacteria. Taken together, our data support the notion 
that calcifying nanoparticles are living materials, rather than 
protein or hydroxyapatite.
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cultivation. However, cultivation of calcifying nanoparticles 
required RPMI 1640 or Dulbecco’s Modified Eagle’s 
Medium with fetal bovine serum, which is not required for 
pathogenic bacteria. This suggests a possible way to detect 
infectious agents in cases of placental calcification or other 
infectious diseases of unknown etiology. Some studies have 
shown that antinanobacterial therapy is helpful for many 
nanobacteria-related diseases.49–52 These medicines may 
be used to treat placental calcification, hypospadias, and 
rickets in the future. In our study, ultrasonic diagnosis of 
placental calcification was confirmed by the presence of 
placental calcification in the placental tissues obtained by 
cesarean section. Thus, despite variability in other factors 
related to pregnancy, tissues with calcification degrees 
1–3 were included in our study. Our study suggests that 
routine detection of calcifying nanoparticles may lead to 
new diagnostic and therapeutic methods in the management 
of diseases associated with placental calcification. 
Calcifying nanoparticles may even be used as a material 
for filling teeth and bone because of their hydroxyapatite 
components.
Calcifying nanoparticles could either result from or 
cause placental calcification. Studies have shown that 
the vitamin D receptor is not required for fetal mineral 
homeostasis or regulation of placental calcium transfer in 
mice,53 so further studies are necessary to determine how 
calcifying nanoparticles induce or exacerbate calcification 
and to clarify the relationship between pregnant women with 
placental calcification and stone formation. Understanding of 
calcifying nanoparticles in placental calcification may lead 
to new strategies in the prevention, diagnosis, and treatment 
of this condition in pregnant women, infants, children, and 
even adults.
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